Global Bacille Calmette-Guérin Vaccine Market Research Report 2025(Status and Outlook)
Description
Report Overview
Bacille Calmette-Guérin (BCG) vaccine is a live attenuated vaccine primarily used for the prevention of tuberculosis. It is derived from a strain of Mycobacterium bovis that has been weakened to reduce its virulence while still stimulating an immune response. The vaccine is administered through intradermal injection and is known for its ability to provide protection against severe forms of tuberculosis, particularly in children. BCG vaccination is recommended in many countries with a high prevalence of tuberculosis to reduce the burden of the disease.
The market for BCG vaccine is influenced by several key trends and market drivers. One significant trend is the increasing focus on preventive healthcare measures, especially in regions where tuberculosis is endemic. Governments and healthcare organizations are actively promoting vaccination programs to control the spread of tuberculosis, which drives the demand for BCG vaccine. Additionally, advancements in vaccine technology and manufacturing processes have led to improvements in the efficacy and safety profile of BCG vaccines, further boosting their adoption rates.
Market drivers for BCG vaccine include the rising global burden of tuberculosis and the need for effective prevention strategies. The World Health Organization (WHO) estimates that tuberculosis remains one of the top 10 causes of death worldwide, underscoring the importance of vaccination in high-risk populations. Furthermore, initiatives such as the Global Vaccine Action Plan aim to increase access to vaccines in low- and middle-income countries, creating opportunities for market growth. In addition, collaborations between governments, non-profit organizations, and vaccine manufacturers play a crucial role in expanding the reach of BCG vaccination programs, driving market expansion and ensuring broader immunization coverage.
The global Bacille Calmette-Guérin Vaccine market size was estimated at USD 158.24 million in 2024 and is projected to reach USD 256.04 million by 2033, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Bacille Calmette-Guérin Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacille Calmette-Guérin Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacille Calmette-Guérin Vaccine market in any manner.
Global Bacille Calmette-Guérin Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
GSBPL
Market Segmentation (by Type)
Immune Bacille Calmette-Guérin
Therapy Bacille Calmette-Guérin
Market Segmentation (by Application)
Infants Under 3 Months
Children Test Negative With 5IUPPD
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Bacille Calmette-Guérin Vaccine Market
Overview of the regional outlook of the Bacille Calmette-Guérin Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bacille Calmette-Guérin Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Bacille Calmette-Guérin Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Bacille Calmette-Guérin (BCG) vaccine is a live attenuated vaccine primarily used for the prevention of tuberculosis. It is derived from a strain of Mycobacterium bovis that has been weakened to reduce its virulence while still stimulating an immune response. The vaccine is administered through intradermal injection and is known for its ability to provide protection against severe forms of tuberculosis, particularly in children. BCG vaccination is recommended in many countries with a high prevalence of tuberculosis to reduce the burden of the disease.
The market for BCG vaccine is influenced by several key trends and market drivers. One significant trend is the increasing focus on preventive healthcare measures, especially in regions where tuberculosis is endemic. Governments and healthcare organizations are actively promoting vaccination programs to control the spread of tuberculosis, which drives the demand for BCG vaccine. Additionally, advancements in vaccine technology and manufacturing processes have led to improvements in the efficacy and safety profile of BCG vaccines, further boosting their adoption rates.
Market drivers for BCG vaccine include the rising global burden of tuberculosis and the need for effective prevention strategies. The World Health Organization (WHO) estimates that tuberculosis remains one of the top 10 causes of death worldwide, underscoring the importance of vaccination in high-risk populations. Furthermore, initiatives such as the Global Vaccine Action Plan aim to increase access to vaccines in low- and middle-income countries, creating opportunities for market growth. In addition, collaborations between governments, non-profit organizations, and vaccine manufacturers play a crucial role in expanding the reach of BCG vaccination programs, driving market expansion and ensuring broader immunization coverage.
The global Bacille Calmette-Guérin Vaccine market size was estimated at USD 158.24 million in 2024 and is projected to reach USD 256.04 million by 2033, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Bacille Calmette-Guérin Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacille Calmette-Guérin Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacille Calmette-Guérin Vaccine market in any manner.
Global Bacille Calmette-Guérin Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
GSBPL
Market Segmentation (by Type)
Immune Bacille Calmette-Guérin
Therapy Bacille Calmette-Guérin
Market Segmentation (by Application)
Infants Under 3 Months
Children Test Negative With 5IUPPD
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Bacille Calmette-Guérin Vaccine Market
Overview of the regional outlook of the Bacille Calmette-Guérin Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bacille Calmette-Guérin Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Bacille Calmette-Guérin Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Table of Contents
158 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Bacille Calmette-Guérin Vaccine
- 1.2 Key Market Segments
- 1.2.1 Bacille Calmette-Guérin Vaccine Segment by Type
- 1.2.2 Bacille Calmette-Guérin Vaccine Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Bacille Calmette-Guérin Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Bacille Calmette-Guérin Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Bacille Calmette-Guérin Vaccine Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Bacille Calmette-Guérin Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Bacille Calmette-Guérin Vaccine Product Life Cycle
- 3.3 Global Bacille Calmette-Guérin Vaccine Sales by Manufacturers (2020-2025)
- 3.4 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Bacille Calmette-Guérin Vaccine Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Bacille Calmette-Guérin Vaccine Sales Sites, Area Served, Product Type
- 3.8 Bacille Calmette-Guérin Vaccine Market Competitive Situation and Trends
- 3.8.1 Bacille Calmette-Guérin Vaccine Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Bacille Calmette-Guérin Vaccine Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Bacille Calmette-Guérin Vaccine Industry Chain Analysis
- 4.1 Bacille Calmette-Guérin Vaccine Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Bacille Calmette-Guérin Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 PEST Analysis
- 5.6.1 Industry Policies Analysis
- 5.6.2 Economic Environment Analysis
- 5.6.3 Social Environment Analysis
- 5.6.4 Technological Environment Analysis
- 5.7 Global Bacille Calmette-Guérin Vaccine Market Porter's Five Forces Analysis
- 5.7.1 Global Trade Frictions
- 5.7.2 Global Trade Frictions and Their Impacts to Bacille Calmette-Guérin Vaccine Market
- 5.8 ESG Ratings of Leading Companies
- 6 Bacille Calmette-Guérin Vaccine Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2020-2025)
- 6.3 Global Bacille Calmette-Guérin Vaccine Market Size Market Share by Type (2020-2025)
- 6.4 Global Bacille Calmette-Guérin Vaccine Price by Type (2020-2025)
- 7 Bacille Calmette-Guérin Vaccine Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Bacille Calmette-Guérin Vaccine Market Sales by Application (2020-2025)
- 7.3 Global Bacille Calmette-Guérin Vaccine Market Size (M USD) by Application (2020-2025)
- 7.4 Global Bacille Calmette-Guérin Vaccine Sales Growth Rate by Application (2020-2025)
- 8 Bacille Calmette-Guérin Vaccine Market Sales by Region
- 8.1 Global Bacille Calmette-Guérin Vaccine Sales by Region
- 8.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Region
- 8.1.2 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Region
- 8.2 Global Bacille Calmette-Guérin Vaccine Market Size by Region
- 8.2.1 Global Bacille Calmette-Guérin Vaccine Market Size by Region
- 8.2.2 Global Bacille Calmette-Guérin Vaccine Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Bacille Calmette-Guérin Vaccine Sales by Country
- 8.3.2 North America Bacille Calmette-Guérin Vaccine Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Bacille Calmette-Guérin Vaccine Sales by Country
- 8.4.2 Europe Bacille Calmette-Guérin Vaccine Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Region
- 8.5.2 Asia Pacific Bacille Calmette-Guérin Vaccine Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Bacille Calmette-Guérin Vaccine Sales by Country
- 8.6.2 South America Bacille Calmette-Guérin Vaccine Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Bacille Calmette-Guérin Vaccine Sales by Region
- 8.7.2 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Bacille Calmette-Guérin Vaccine Market Production by Region
- 9.1 Global Production of Bacille Calmette-Guérin Vaccine by Region(2020-2025)
- 9.2 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2020-2025)
- 9.3 Global Bacille Calmette-Guérin Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Bacille Calmette-Guérin Vaccine Production
- 9.4.1 North America Bacille Calmette-Guérin Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Bacille Calmette-Guérin Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Bacille Calmette-Guérin Vaccine Production
- 9.5.1 Europe Bacille Calmette-Guérin Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Bacille Calmette-Guérin Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Bacille Calmette-Guérin Vaccine Production (2020-2025)
- 9.6.1 Japan Bacille Calmette-Guérin Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Bacille Calmette-Guérin Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Bacille Calmette-Guérin Vaccine Production (2020-2025)
- 9.7.1 China Bacille Calmette-Guérin Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Bacille Calmette-Guérin Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Merck
- 10.1.1 Merck Basic Information
- 10.1.2 Merck Bacille Calmette-Guérin Vaccine Product Overview
- 10.1.3 Merck Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.1.4 Merck Business Overview
- 10.1.5 Merck SWOT Analysis
- 10.1.6 Merck Recent Developments
- 10.2 Sanofi Pasteur
- 10.2.1 Sanofi Pasteur Basic Information
- 10.2.2 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Overview
- 10.2.3 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.2.4 Sanofi Pasteur Business Overview
- 10.2.5 Sanofi Pasteur SWOT Analysis
- 10.2.6 Sanofi Pasteur Recent Developments
- 10.3 Japan BCG Lab
- 10.3.1 Japan BCG Lab Basic Information
- 10.3.2 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Overview
- 10.3.3 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.3.4 Japan BCG Lab Business Overview
- 10.3.5 Japan BCG Lab SWOT Analysis
- 10.3.6 Japan BCG Lab Recent Developments
- 10.4 China National Biotec
- 10.4.1 China National Biotec Basic Information
- 10.4.2 China National Biotec Bacille Calmette-Guérin Vaccine Product Overview
- 10.4.3 China National Biotec Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.4.4 China National Biotec Business Overview
- 10.4.5 China National Biotec Recent Developments
- 10.5 Serum Institute of India
- 10.5.1 Serum Institute of India Basic Information
- 10.5.2 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Overview
- 10.5.3 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.5.4 Serum Institute of India Business Overview
- 10.5.5 Serum Institute of India Recent Developments
- 10.6 GSBPL
- 10.6.1 GSBPL Basic Information
- 10.6.2 GSBPL Bacille Calmette-Guérin Vaccine Product Overview
- 10.6.3 GSBPL Bacille Calmette-Guérin Vaccine Product Market Performance
- 10.6.4 GSBPL Business Overview
- 10.6.5 GSBPL Recent Developments
- 11 Bacille Calmette-Guérin Vaccine Market Forecast by Region
- 11.1 Global Bacille Calmette-Guérin Vaccine Market Size Forecast
- 11.2 Global Bacille Calmette-Guérin Vaccine Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Bacille Calmette-Guérin Vaccine Market Size Forecast by Country
- 11.2.3 Asia Pacific Bacille Calmette-Guérin Vaccine Market Size Forecast by Region
- 11.2.4 South America Bacille Calmette-Guérin Vaccine Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Bacille Calmette-Guérin Vaccine by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Bacille Calmette-Guérin Vaccine Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Bacille Calmette-Guérin Vaccine by Type (2026-2033)
- 12.1.2 Global Bacille Calmette-Guérin Vaccine Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Bacille Calmette-Guérin Vaccine by Type (2026-2033)
- 12.2 Global Bacille Calmette-Guérin Vaccine Market Forecast by Application (2026-2033)
- 12.2.1 Global Bacille Calmette-Guérin Vaccine Sales (K MT) Forecast by Application
- 12.2.2 Global Bacille Calmette-Guérin Vaccine Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
